Jubilant Pharmova's Singapore subsidiary redeems Notes aggregating USD 300 mn
Capital MarketJubilant Pharmova announced that its wholly owned subsidiary in Singapore, Jubilant Pharma has on 05 March 2021 redeemed the principal
amount of US$100,000,000 out of US$300,000,000 Notes at a redemption price of 101.21875% together with the accrued interest till date. JPL had made the first early redemption of
US$100,000,000 in November 2019 and the second early redemption of US$100,000,000 on 29 January 2021.
After the redemption of US$100,000,000 on 05 March 2021, the Notes have
been paid in full and no amount remains outstanding under the Notes.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
